Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas

Pediatric Hematology and Oncology

Volumn 21, Issue 8, 2004, Pages 717-723

  Yalçin, Bilgehan ^a   Canpinar, Hande ^a   Kutluk, M Tezer ^a   Varan, Ali ^a   Akyüz, Canan ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cerebrospinal fluid; Children; Non Hodgkin lymphomas; Soluble CD27

Indexed keywords

ANTINEOPLASTIC AGENT; CD27 ANTIGEN; SOLUBLE CD27 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN DETECTION; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; NONHODGKIN LYMPHOMA; PEDIATRICS; PROTEIN BLOOD LEVEL; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANTIGENS, CD27; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC ERRORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; LYMPHOMA, NON-HODGKIN; MALE; MENINGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STATISTICAL DISTRIBUTIONS;

EID: 9644265263     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010490514903     Document Type: Article

References (17)

1. Glantz MJ, Cole DF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998;82:733-739.
2. Kersten MJ, Evers LM, Dellemijn PLI, et al. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood. 1996;87:1985-1989.
3. van den Bent MJ, Lamers CH, vant Veer MB, et al. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies. Ann Hematol. 2002;81:187-191.
4. Hanley JA, Mc Neil BJ. The meaning and the use of the area under the receiver operating characteristics (ROC) curve. Radiology. 1982;143:29-36.
5. Bigner SH, Johnston WW. The cytopathology of cerebrospinal fluid, 1: non-neoplastic conditions, lymphoma and leukemia. Acta Cytol. 1981;25:345-353.
6. Marton KI, Gean AD. The spinal tap: a new look at an old test. Ann Inter Med. 1986;104:840-848.
7. Hovestadt A, Henzen-Logmans SC, Vecht Ch. J. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. Br J Cancer. 1990;62:653-654.
8. Weller M, Stevens A, Sommer N, et al. Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia. Acta Neurol Scand. 1992;86:129-133.
9. Hansen PB, Kjeldsen L, Dalhoff K, Olesen B. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS involvement. Acta Neurol Scand. 1992;85:224-227.
10. Maylight GM, Stuckey SE, Cabanillas FF, et al. Diagnosis of leukemia or lymphoma in the central nervous system by beta-2-microglobulin determination. N Engl J. Med. 1980;303:718-722.
11. Jeffery GM, Frampton CM, Legge HM, Hart DN. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy. Pathology. 1990;22:20-23.
12. Pudek MR, Chan KW, Rogers PC, Teasdale JM. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma. Clin Biochem. 1985;18:180-183.
13. Hintzen RQ, de Jong R, Hack CE, et al. A soluble form of the human T-cell differentiation antigen CD27 is released after triggering of the TCR/CDS complex. J Immunol. 1991;147:29-35.
14. Hintzen RQ, van Lier RA, Kuijpers KC, et al. Elevated levels of a soluble form of the T cell activation antigen in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol. 1991;35:211-217.
15. Chamuleau MED, ten, Berge IJ, Schellekens PTA, et al. Serum levels of soluble CD27 in renal transplant recipients. Transplantation. 1992;54:932-936.
16. Font J, Pallares L, Martorell J, et al. Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1996;81:239-243.
17. van Oers MHJ, Pals ST, Evers LM, et al. Expression and release of CD27 in human B-cell malignancies. Blood. 1993;82:3430-3436.